These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series. Ferrigno R, Nishimoto IN, Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Salvajoli JV. Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1108-16. PubMed ID: 15990016 [Abstract] [Full Text] [Related]
4. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer. Wang CJ, Huang EY, Sun LM, Chen HC, Fang FM, Hsu HC, Changchien CC, Leung SW. Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):179-89. PubMed ID: 15093915 [Abstract] [Full Text] [Related]
5. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma. Lu JJ, Shakespeare TP, Tan LK, Goh BC, Cooper JS. Head Neck; 2004 May 01; 26(5):389-95. PubMed ID: 15122654 [Abstract] [Full Text] [Related]
16. Prospective study of HDR (192Ir) versus MDR (137Cs) intracavitary brachytherapy for carcinoma of the uterine cervix. Tanaka E, Oh RJ, Yamada Y, Shiomi H, Nakamura S, Shimamoto S, Teshima T, Inoue T, Inoue T. Brachytherapy; 2003 May 01; 2(2):85-90. PubMed ID: 15062145 [Abstract] [Full Text] [Related]
19. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy. Yoshimura R, Hayashi K, Ayukawa F, Toda K, Iwata M, Oota S, Hoshi A, Wakatsuki M, Kurosaki H, Okazaki A, Shibuya H. Brachytherapy; 2008 May 01; 7(3):260-6. PubMed ID: 18579445 [Abstract] [Full Text] [Related]